Unfunded cancer treatment needed 26-year-old's survival
Massey resident Tegan Hollier, 26, received a shock diagnosis of stage four bowel cancer, "teetering on curable", on January 15, despite having almost no symptoms. However, she has since been told her only chance at survival is Keytruda, an unfunded immunotherapy drug with a $112,000 price tag, due to also being diagnosed with Lynch Syndrome, which doesn't respond well to chemotherapy.
"I'm just really angry, because literally my life is in my own hands and now it depends if I can get enough money. It's pretty heartbreaking really," said Hollier, who returned to work less than a month after having major surgery.
The drug Hollier needs is only funded for advanced melanoma, despite having dramatic results for Lynch Syndrome patients worldwide.
Should Keytruda be funded in NZ?
Today’s Mind-Bender is the Last of the Year! Can You Guess It Before Everyone Else? 🌟🎁🌲
I dance in the sky with green and gold, a spectacle few are lucky to behold; I’m best seen in the south, a celestial sight—what am I, lighting up the New Zealand night?
Do you think you know the answer? Simply 'Like' this post and we'll post the answer in the comments below at 2pm on the day!
Want to stop seeing these in your newsfeed? No worries! Simply head here and click once on the Following button.
No gift? No stress
Let the Christmas elves at Mags4gifts.co.nz handle your last-minute shopping. For a limited time, gift a subscription with up to 40% off best-sellers like TV Guide, NZ House & Garden, and NZ Gardener. It’s the perfect Christmas present, sorted in minutes (and no one needs to know it was a last-minute surprise)!
Loading…